Cargando…
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER(+) breast cancer
Extensive knowledge has been gained on the transcription network controlled by ERα, however, the mechanism underlying ESR1 (encoding ERα) expression is less understood. We recently discovered that the Hippo pathway is required for the proper expression of ESR1. YAP/TAZ are transcription coactivators...
Autores principales: | Ma, Shenghong, Tang, Tracy, Probst, Gary, Konradi, Andrei, Jin, Chunyu, Li, Fulong, Gutkind, J. Silvio, Fu, Xiang-Dong, Guan, Kun-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881512/ https://www.ncbi.nlm.nih.gov/pubmed/35217640 http://dx.doi.org/10.1038/s41467-022-28691-0 |
Ejemplares similares
-
Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
por: Faraji, Farhoud, et al.
Publicado: (2022) -
Polycystic kidney disease: a Hippo connection
por: Ma, Shenghong, et al.
Publicado: (2018) -
YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019) -
Oncotargeting G proteins: The Hippo in the room
por: Feng, Xiaodong, et al.
Publicado: (2014) -
S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells
por: Li, Yunguang, et al.
Publicado: (2016)